EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Markers in Infants of Mothers With Asthma and Associations With Respiratory Outcomes

Carla Rebeca Da Silva Sena, Gabriela Martins Costa Gomes, Noëmi Künstle, Olga Gorlanova iD, Andrea Marten, Sven Schulzke, Florian Wyler, Vanessa E Murphy iD, Paul D Robinson, Peter D Sly, Jakob Usemann, Benjamin Stoecklin und 10 weitere

Allergy · 2026-01 · 81 (1) · 145-156

DOI: 10.1111/all.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 15.09.2025. Verfasst von Carla Rebeca Da Silva Sena und 21 weiteren Autor:innen. Beteiligte Einrichtung: University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Asthma, Biomarkers, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union H2020, European Respiratory Society, Hunter Children's Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In utero mechanisms related to oxidative stress response, inflammation, and extracellular matrix turnover may influence fetal lung development in the offspring of asthmatic mothers. Therefore, we aimed to determine whether levels of cord blood proteins differ between the offspring of asthmatic and nonasthmatic mothers. In addition, we aimed to examine if these proteins are associated with infant lung function, bronchiolitis hospitalization in infancy, and asthma at six years.

Methods

We compared protein levels of infants ( n = 715) from the Swiss Basel‐Bern Infant Lung Development and the Australian Breathing for Life Trial birth cohorts using Tobit regression and network analyses. Using adjusted linear and logistic regression, we determined their association with postnatal infant lung function, bronchiolitis hospitalization in infancy, and asthma at six years.

Results

Infants born to asthmatic mothers had lower levels of matrix metalloproteinase‐9 (MMP‐9, β ‐coefficient [ β ] −0.67, 95% confidence interval [−1.07; −0.27] p adj = 0.009) and Interferon gamma (IFN‐γ, β −0.77 [−1.21; −0.32], p adj = 0.009), and higher levels of p62 ( β 1.15 [0.30; 2.00], p adj = 0.030). p62 levels were inversely associated with minute ventilation ( β −16.18 [−28.44; −3.91], p adj = 0.032). Functional residual capacity values were inversely associated with both IFN‐γ ( β −1.26, [−2.41; −0.11], p adj = 0.063) and MMP‐9 levels ( β −1.27, [−2.53; −0.01], p adj = 0.063). MMP‐9 levels were inversely associated with both the risk of bronchiolitis hospitalization (odds ratio 0.47, [0.29; 0.77], p adj = 0.004) and the risk of asthma (aOR 0.53, 95% CI, 0.32–0.86, p adj = 0.033).

Conclusions

Protein levels differed between offspring of asthmatic and non‐asthmatic mothers. These markers were associated with postnatal lung function, bronchiolitis hospitalization, and asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaBiomarkersPrenatal Exposure Delayed EffectsHumansFemalePregnancyInfantMaleMothersInfant, NewbornRespiratory Function TestsAdultChildBronchiolitisFetal Blood

Stichwörter der Autor:innen

asthmaasthma during pregnancybronchiolitisinfant lung functionproteins

Substanzen

Biomarkers

Autor:innen und Institutionen

  • University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
  • Asthma & Breathing Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • University of Newcastle, Newcastle, New South Wales, Australia.
  • Division of Pediatric Respiratory Medicine and Allergology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Respiratory Medicine, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Children's Health and Environment Program, Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Olga Gorlanova, Vanessa E Murphy, Urs Frey

Förderung

  • European Union H2020
  • European Respiratory Society
  • Hunter Children's Research Foundation
  • Priority Research Centre GrowUpWell
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Marie Sklodowska-Curie Grant
  • Rebecca L. Cooper Medical Research Foundation
  • National Health and Medical Research Council Australia

Zitieren

APA

Da Silva Sena, C. R., Martins Costa Gomes, G., Künstle, N., Gorlanova, O., Marten, A., Schulzke, S., Wyler, F., Murphy, V. E., Robinson, P. D., Sly, P. D., Usemann, J., Stoecklin, B., Steinberg, R., Yammine, S., Müller, L., Latzin, P., Sinues, P., Gibson, P. G., Mattes, J., …, & BILD and BLT Study Groups (2026). Markers in Infants of Mothers With Asthma and Associations With Respiratory Outcomes. Allergy, 81(1), 145-156. https://doi.org/10.1111/all.70044

Vancouver

Da Silva Sena CR, Martins Costa Gomes G, Künstle N, Gorlanova O, Marten A, Schulzke S, et al. Markers in Infants of Mothers With Asthma and Associations With Respiratory Outcomes. Allergy. 2026;81(1):145-156. doi:10.1111/all.70044

BibTeX
@article{DaSilvaSena2026,
  author = {Da Silva Sena, Carla Rebeca and Martins Costa Gomes, Gabriela and Künstle, Noëmi and Gorlanova, Olga and Marten, Andrea and Schulzke, Sven and Wyler, Florian and Murphy, Vanessa E and Robinson, Paul D and Sly, Peter D and Usemann, Jakob and Stoecklin, Benjamin and Steinberg, Ruth and Yammine, Sophie and Müller, Loretta and Latzin, Philipp and Sinues, Pablo and Gibson, Peter G and Mattes, Joerg and Collison, Adam and Frey, Urs and BILD and BLT Study Groups, BILD and BLT Study Groups},
  title = {Markers in Infants of Mothers With Asthma and Associations With Respiratory Outcomes},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {1},
  pages = {145--156},
  doi = {10.1111/all.70044}
}
Kostenlos starten →